Showing results (181-190 of 237) with videos related to
Sort By:
Pageof 24
Frontiers in Plant Science|April 11, 2022
Dry Season Transpiration and Soil Water Dynamics in the Central AmazonGustavo C Spanner, Bruno O Gimenez, Cynthia L Wright, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 24, 2021
Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE TrialHiddo J L Heerspink, Megumi Oshima, Hong Zhang, et al.Plants (Basel, Switzerland)|May 3, 2016
Green Leaf Volatile Emissions during High Temperature and Drought Stress in a Central Amazon RainforestKolby J Jardine, Jeffrey Q Chambers, Jennifer Holm, et al.Journal of the American Society of Nephrology : JASN|February 3, 2017
A Trial of Extending Hemodialysis Hours and Quality of LifeMeg J Jardine, Li Zuo, Nicholas A Gray, et al.ESC Heart Failure|February 17, 2021
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS ProgramJie Yu, Clare Arnott, Brendon L Neuen, et al.Kidney International|November 11, 2019
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceCatherine M Clase, Juan-Jesus Carrero, David H Ellison, et al.Hemodialysis International. International Symposium on Home Hemodialysis|July 9, 2016
Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis unitsHilary M Miller, Allison Tong, David J Tunnicliffe, et al.Journal of the American Society of Nephrology : JASN|October 25, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD TrialsRobert A Fletcher, Niels Jongs, Glenn M Chertow, et al.Journal of the American Heart Association|June 22, 2023
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE TrialsRobert A Fletcher, Clare Arnott, Patrick Rockenschaub, et al.Blood Purification|January 23, 2020
A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device StudyRathika Krishnasamy, Carmel M Hawley, Meg J Jardine, et al.Pageof 24